R. L. Parsons

An Efficient Large-Scale Process for the Human Leukocyte Elastase Inhibitor, DMP 7771

W. A. Nugent, J. Fortunak, W. P. Davis, 2002 .

Structural and rate studies of the 1,2-additions of lithium phenylacetylide to lithiated quinazolinones: influence of mixed aggregates on the reaction mechanism.

D. B. Collum, J. Fortunak, P. Confalone, 2004, Journal of the American Chemical Society.

An efficient chiral moderator prepared from inexpensive (+)-3-carene: synthesis of the HIV-1 non-nucleoside reverse transcriptase inhibitor DPC 963.

W. A. Nugent, J. Fortunak, P. Confalone, 2000, Organic letters.

Synthesis and evaluation of efavirenz (Sustiva) analogues as HIV-1 reverse transcriptase inhibitors: replacement of the cyclopropylacetylene side chain.

L. Bacheler, G. Trainor, A. Cocuzza, 2001, Bioorganic & medicinal chemistry letters.

General scope of 1,4-diastereoselective additions to a 2(3H)-quinazolinone: practical preparation of HIV therapeutics.

W. P. Davis, P. Confalone, N. Magnus, 2003, The Journal of organic chemistry.

Selection of an Enantioselective Process for the Preparation of a CGRP Receptor Inhibitor

W. A. Nugent, R. Nielsen, R. Hanson, 2012 .

NMR spectroscopic investigations of mixed aggregates underlying highly enantioselective 1,2-additions of lithium cyclopropylacetylide to quinazolinones.

W. A. Nugent, D. B. Collum, J. Fortunak, 2001, Journal of the American Chemical Society.